BLOOMBERG Bloomberg Markets Americas November 29, 2016
Move higher this morning. If you look at another developing story that we have been covering, johnson and johnson raised its offer for actelion. The largest biotech firm in europe. J j raised its bid from an earlier bid to 242 a share or 26 billion. This was Company Rejected it as too low. Actelion is higher by 6 , getting a bump up after these headlines. We will continue to monitor this developing story with what is potentially a large acquisition on the part of j j. Hitting back to the u. S. And stocks, very little change in the major averages. A couple of competing impulses. You have Econom...